BURVILL HOUSE SURGERY — All Prescriptions & Medications — Page 3
Practice Code: E82023 | HATFIELD, AL10 8HP
Showing results 101-150 of 574
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 327 | 338 | £1.6K | +38.4% ▲ | |
| Warfarin sodium | 326 | 16.9K | £602 | -30.9% ▼ |
| Lisinopril | 323 | 11.8K | £255 | -70.5% ▼ |
| 313 | 323 | £436 | +42.0% ▲ | |
| Tiotropium bromide | 308 | 6,470 | £8.5K | +1.3% vs avg |
| Famotidine | 306 | 10.2K | £6.1K | -37.3% ▼ |
| Levetiracetam | 303 | 43.7K | £1.7K | -33.8% ▼ |
| Umeclidinium bromide/vilanterol | 302 | 313 | £9.7K | +54.9% ▲ |
| Nifedipine | 299 | 11.2K | £1.8K | +59.5% ▲ |
| Dimeticone (Barrier) | 297 | 146.0K | £1.4K | +1,918.8% ▲ |
| Dulaglutide | 293 | 1,284 | £23.5K | +155.7% ▲ |
| Quinine sulfate | 292 | 5,257 | £919 | +0.9% vs avg |
| Co-careldopa (Carbidopa/levodopa) | 285 | 27.0K | £2.1K | +26.1% ▲ |
| Loratadine | 284 | 9,713 | £220 | +35.9% ▲ |
| Digoxin | 279 | 6,950 | £514 | -26.3% ▼ |
| Clobetasone butyrate | 273 | 18.6K | £1.8K | +33.8% ▲ |
| Procyclidine hydrochloride | 262 | 12.9K | £500 | +85.2% ▲ |
| Canagliflozin | 261 | 7,478 | £9.3K | +81.8% ▲ |
| Beclometasone dipropionate | 260 | 263 | £788 | +20.9% ▲ |
| Hydroxychloroquine sulfate | 257 | 8,472 | £495 | +32.7% ▲ |
| Semaglutide | 254 | 5,025 | £20.7K | +5.5% ▲ |
| Perindopril erbumine | 249 | 9,514 | £884 | -53.1% ▼ |
| Latanoprost | 249 | 3,003 | £1.1K | -48.7% ▼ |
| Mometasone furoate | 249 | 270 | £2.1K | -38.0% ▼ |
| Betamethasone valerate | 247 | 21.3K | £1.5K | -35.8% ▼ |
| Lactulose | 244 | 167.2K | £1.6K | -25.9% ▼ |
| Risperidone | 243 | 8,807 | £494 | -4.0% ▼ |
| Tolterodine | 243 | 7,700 | £1.2K | +63.4% ▲ |
| Diazepam | 239 | 5,952 | £137 | -52.0% ▼ |
| Carbamazepine | 239 | 19.4K | £987 | -19.5% ▼ |
| Insulin degludec | 238 | 1,264 | £12.0K | +116.6% ▲ |
| Methylphenidate hydrochloride | 236 | 11.9K | £8.8K | -8.6% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 229 | 23.1K | £1.2K | +27.4% ▲ |
| 227 | 79.2K | £1.4K | -14.0% ▼ | |
| 223 | 2,059 | £752 | -10.6% ▼ | |
| Irbesartan | 219 | 6,657 | £270 | -10.1% ▼ |
| Enalapril maleate | 213 | 8,064 | £369 | +18.5% ▲ |
| Fluticasone furoate/vilanterol | 213 | 217 | £5.4K | +37.6% ▲ |
| Glyceryl trinitrate | 212 | 1,036 | £719 | -10.4% ▼ |
| Dihydrocodeine tartrate | 211 | 20.1K | £1.5K | +8.0% ▲ |
| Trimethoprim | 210 | 4,755 | £341 | +2.8% ▲ |
| Lithium carbonate | 209 | 6,832 | £1.0K | +64.7% ▲ |
| Methotrexate | 209 | 5,566 | £614 | -35.8% ▼ |
| 205 | 25.0K | £1.3K | -25.9% ▼ | |
| Mebeverine hydrochloride | 204 | 13.4K | £405 | -34.3% ▼ |
| Biphasic isophane insulin | 204 | 1,423 | £6.1K | +82.9% ▲ |
| Miconazole nitrate | 200 | 7,650 | £1.2K | +182.7% ▲ |
| 200 | 2,325 | £489 | -4.3% ▼ | |
| Mirabegron | 199 | 4,990 | £4.6K | -50.5% ▼ |
| Aciclovir | 195 | 7,972 | £376 | +31.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.